What is known about the immune response induced by Plasmodium vivax malaria vaccine candidates?
Malaria caused by Plasmodium vivax continues being one of the most important infectious diseases around the world; P. vivax is the second most prevalent species and has the greatest geographic distribution. Developing an effective antimalarial vaccine is considered a relevant control strategy in the...
- Autores:
- Tipo de recurso:
- Fecha de publicación:
- 2017
- Institución:
- Universidad del Rosario
- Repositorio:
- Repositorio EdocUR - U. Rosario
- Idioma:
- eng
- OAI Identifier:
- oai:repository.urosario.edu.co:10336/24090
- Acceso en línea:
- https://doi.org/10.3389/fimmu.2017.00126
https://repository.urosario.edu.co/handle/10336/24090
- Palabra clave:
- Apical membrane antigen 1
Chemokine
Circumsporozoite protein
Duffy binding protein
Malaria vaccine
Merozoite surface protein 3
Merozoite surface protein 9
Protozoal protein
Recombinant protein
Synthetic peptide
Transcription factor
Unclassified drug
Adaptive immunity
Antigen binding
B lymphocyte
Cell invasion
Disease severity
Geographic distribution
Helper cell
Host cell
Human
Immune response
Immunological tolerance
Inflammation
Innate immunity
Macrophage activation
Minor histocompatibility complex
Natural killer cell
Neuromuscular blocking
Nonhuman
Pathogenesis
Phagolysosome
Plasmodium vivax malaria
Review
Serology
Sporozoite
T lymphocyte activation
Vaccine immunogenicity
Antigenicity
Immune response
Immunogenicity
Malaria
Plasmodium vivax
- Rights
- License
- Abierto (Texto Completo)
id |
EDOCUR2_652d1417a31e06156ca496e525fec390 |
---|---|
oai_identifier_str |
oai:repository.urosario.edu.co:10336/24090 |
network_acronym_str |
EDOCUR2 |
network_name_str |
Repositorio EdocUR - U. Rosario |
repository_id_str |
|
spelling |
f04dd5c4-d685-4cee-a3d9-d2c759ef003f-1cefe4575-665d-4fc3-8e86-c6715477a2fd-17a7ab596-67bd-43b1-9ba1-8ec6c572d2df-179653065-1518948826002020-05-26T00:08:31Z2020-05-26T00:08:31Z2017Malaria caused by Plasmodium vivax continues being one of the most important infectious diseases around the world; P. vivax is the second most prevalent species and has the greatest geographic distribution. Developing an effective antimalarial vaccine is considered a relevant control strategy in the search for means of preventing the disease. Studying parasite-expressed proteins, which are essential in host cell invasion, has led to identifying the regions recognized by individuals who are naturally exposed to infection. Furthermore, immunogenicity studies have revealed that such regions can trigger a robust immune response that can inhibit sporozoite (hepatic stage) or merozoite (erythrocyte stage) invasion of a host cell and induce protection. This review provides a synthesis of the most important studies to date concerning the antigenicity and immunogenicity of both synthetic peptide and recombinant protein candidates for a vaccine against malaria produced by P. vivax. © 2017 López, Yepes-Pérez, Hincapié-Escobar, Díaz-Arévalo and Patarroyo.application/pdfhttps://doi.org/10.3389/fimmu.2017.0012616643224https://repository.urosario.edu.co/handle/10336/24090engFrontiers Research FoundationNo. FEBFrontiers in ImmunologyVol. 8Frontiers in Immunology, ISSN:16643224, Vol.8, No.FEB (2017)https://www.scopus.com/inward/record.uri?eid=2-s2.0-85014341523&doi=10.3389%2ffimmu.2017.00126&partnerID=40&md5=061b587217ac2997fa0bdaf68d6b7f89Abierto (Texto Completo)http://purl.org/coar/access_right/c_abf2instname:Universidad del Rosarioreponame:Repositorio Institucional EdocURApical membrane antigen 1ChemokineCircumsporozoite proteinDuffy binding proteinMalaria vaccineMerozoite surface protein 3Merozoite surface protein 9Protozoal proteinRecombinant proteinSynthetic peptideTranscription factorUnclassified drugAdaptive immunityAntigen bindingB lymphocyteCell invasionDisease severityGeographic distributionHelper cellHost cellHumanImmune responseImmunological toleranceInflammationInnate immunityMacrophage activationMinor histocompatibility complexNatural killer cellNeuromuscular blockingNonhumanPathogenesisPhagolysosomePlasmodium vivax malariaReviewSerologySporozoiteT lymphocyte activationVaccine immunogenicityAntigenicityImmune responseImmunogenicityMalariaPlasmodium vivaxWhat is known about the immune response induced by Plasmodium vivax malaria vaccine candidates?articleArtículohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501López, CarolinaYepes-Pérez, YoelisHincapié-Escobar, NataliaPatarroyo, Manuel A.Díaz Arévalo, DianaORIGINALfimmu-08-00126.pdfapplication/pdf1773731https://repository.urosario.edu.co/bitstreams/a1ecae58-9543-42f1-b3b9-cb25520ab06e/download3eb4a6e9b184d5c8dfdf73b90a29ed8dMD51TEXTfimmu-08-00126.pdf.txtfimmu-08-00126.pdf.txtExtracted texttext/plain149125https://repository.urosario.edu.co/bitstreams/d4711a53-3273-4a45-9350-343342f3e2f8/download25047bffb210dc808b52e5ef98b22904MD52THUMBNAILfimmu-08-00126.pdf.jpgfimmu-08-00126.pdf.jpgGenerated Thumbnailimage/jpeg4410https://repository.urosario.edu.co/bitstreams/0ecaff03-c362-4cbd-a227-c5c71835f034/download356d11c8fcca34b080e0259b6d4668c8MD5310336/24090oai:repository.urosario.edu.co:10336/240902022-05-02 07:37:21.39403https://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.co |
dc.title.spa.fl_str_mv |
What is known about the immune response induced by Plasmodium vivax malaria vaccine candidates? |
title |
What is known about the immune response induced by Plasmodium vivax malaria vaccine candidates? |
spellingShingle |
What is known about the immune response induced by Plasmodium vivax malaria vaccine candidates? Apical membrane antigen 1 Chemokine Circumsporozoite protein Duffy binding protein Malaria vaccine Merozoite surface protein 3 Merozoite surface protein 9 Protozoal protein Recombinant protein Synthetic peptide Transcription factor Unclassified drug Adaptive immunity Antigen binding B lymphocyte Cell invasion Disease severity Geographic distribution Helper cell Host cell Human Immune response Immunological tolerance Inflammation Innate immunity Macrophage activation Minor histocompatibility complex Natural killer cell Neuromuscular blocking Nonhuman Pathogenesis Phagolysosome Plasmodium vivax malaria Review Serology Sporozoite T lymphocyte activation Vaccine immunogenicity Antigenicity Immune response Immunogenicity Malaria Plasmodium vivax |
title_short |
What is known about the immune response induced by Plasmodium vivax malaria vaccine candidates? |
title_full |
What is known about the immune response induced by Plasmodium vivax malaria vaccine candidates? |
title_fullStr |
What is known about the immune response induced by Plasmodium vivax malaria vaccine candidates? |
title_full_unstemmed |
What is known about the immune response induced by Plasmodium vivax malaria vaccine candidates? |
title_sort |
What is known about the immune response induced by Plasmodium vivax malaria vaccine candidates? |
dc.subject.keyword.spa.fl_str_mv |
Apical membrane antigen 1 Chemokine Circumsporozoite protein Duffy binding protein Malaria vaccine Merozoite surface protein 3 Merozoite surface protein 9 Protozoal protein Recombinant protein Synthetic peptide Transcription factor Unclassified drug Adaptive immunity Antigen binding B lymphocyte Cell invasion Disease severity Geographic distribution Helper cell Host cell Human Immune response Immunological tolerance Inflammation Innate immunity Macrophage activation Minor histocompatibility complex Natural killer cell Neuromuscular blocking Nonhuman Pathogenesis Phagolysosome Plasmodium vivax malaria Review Serology Sporozoite T lymphocyte activation Vaccine immunogenicity Antigenicity Immune response Immunogenicity Malaria Plasmodium vivax |
topic |
Apical membrane antigen 1 Chemokine Circumsporozoite protein Duffy binding protein Malaria vaccine Merozoite surface protein 3 Merozoite surface protein 9 Protozoal protein Recombinant protein Synthetic peptide Transcription factor Unclassified drug Adaptive immunity Antigen binding B lymphocyte Cell invasion Disease severity Geographic distribution Helper cell Host cell Human Immune response Immunological tolerance Inflammation Innate immunity Macrophage activation Minor histocompatibility complex Natural killer cell Neuromuscular blocking Nonhuman Pathogenesis Phagolysosome Plasmodium vivax malaria Review Serology Sporozoite T lymphocyte activation Vaccine immunogenicity Antigenicity Immune response Immunogenicity Malaria Plasmodium vivax |
description |
Malaria caused by Plasmodium vivax continues being one of the most important infectious diseases around the world; P. vivax is the second most prevalent species and has the greatest geographic distribution. Developing an effective antimalarial vaccine is considered a relevant control strategy in the search for means of preventing the disease. Studying parasite-expressed proteins, which are essential in host cell invasion, has led to identifying the regions recognized by individuals who are naturally exposed to infection. Furthermore, immunogenicity studies have revealed that such regions can trigger a robust immune response that can inhibit sporozoite (hepatic stage) or merozoite (erythrocyte stage) invasion of a host cell and induce protection. This review provides a synthesis of the most important studies to date concerning the antigenicity and immunogenicity of both synthetic peptide and recombinant protein candidates for a vaccine against malaria produced by P. vivax. © 2017 López, Yepes-Pérez, Hincapié-Escobar, Díaz-Arévalo and Patarroyo. |
publishDate |
2017 |
dc.date.created.spa.fl_str_mv |
2017 |
dc.date.accessioned.none.fl_str_mv |
2020-05-26T00:08:31Z |
dc.date.available.none.fl_str_mv |
2020-05-26T00:08:31Z |
dc.type.eng.fl_str_mv |
article |
dc.type.coarversion.fl_str_mv |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
dc.type.coar.fl_str_mv |
http://purl.org/coar/resource_type/c_6501 |
dc.type.spa.spa.fl_str_mv |
Artículo |
dc.identifier.doi.none.fl_str_mv |
https://doi.org/10.3389/fimmu.2017.00126 |
dc.identifier.issn.none.fl_str_mv |
16643224 |
dc.identifier.uri.none.fl_str_mv |
https://repository.urosario.edu.co/handle/10336/24090 |
url |
https://doi.org/10.3389/fimmu.2017.00126 https://repository.urosario.edu.co/handle/10336/24090 |
identifier_str_mv |
16643224 |
dc.language.iso.spa.fl_str_mv |
eng |
language |
eng |
dc.relation.citationIssue.none.fl_str_mv |
No. FEB |
dc.relation.citationTitle.none.fl_str_mv |
Frontiers in Immunology |
dc.relation.citationVolume.none.fl_str_mv |
Vol. 8 |
dc.relation.ispartof.spa.fl_str_mv |
Frontiers in Immunology, ISSN:16643224, Vol.8, No.FEB (2017) |
dc.relation.uri.spa.fl_str_mv |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85014341523&doi=10.3389%2ffimmu.2017.00126&partnerID=40&md5=061b587217ac2997fa0bdaf68d6b7f89 |
dc.rights.coar.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 |
dc.rights.acceso.spa.fl_str_mv |
Abierto (Texto Completo) |
rights_invalid_str_mv |
Abierto (Texto Completo) http://purl.org/coar/access_right/c_abf2 |
dc.format.mimetype.none.fl_str_mv |
application/pdf |
dc.publisher.spa.fl_str_mv |
Frontiers Research Foundation |
institution |
Universidad del Rosario |
dc.source.instname.spa.fl_str_mv |
instname:Universidad del Rosario |
dc.source.reponame.spa.fl_str_mv |
reponame:Repositorio Institucional EdocUR |
bitstream.url.fl_str_mv |
https://repository.urosario.edu.co/bitstreams/a1ecae58-9543-42f1-b3b9-cb25520ab06e/download https://repository.urosario.edu.co/bitstreams/d4711a53-3273-4a45-9350-343342f3e2f8/download https://repository.urosario.edu.co/bitstreams/0ecaff03-c362-4cbd-a227-c5c71835f034/download |
bitstream.checksum.fl_str_mv |
3eb4a6e9b184d5c8dfdf73b90a29ed8d 25047bffb210dc808b52e5ef98b22904 356d11c8fcca34b080e0259b6d4668c8 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositorio institucional EdocUR |
repository.mail.fl_str_mv |
edocur@urosario.edu.co |
_version_ |
1814167668475822080 |